Movatterモバイル変換

[0]ホーム
URL:

Prijeđi na sadržaj
Wikipedija
Pretraga

Itrakonazol

Izvor: Wikipedija
Itrakonazol
Klinički podaci
Robne markeHyphanox, Itrizole, Oriconazole, Sporal
AHFS/Drugs.comMonografija
Identifikatori
CAS broj84625-61-6
ATC kodJ02AC02
PubChem[1][2]55283
DrugBankDB01167
ChemSpider[3]49927
ChEBICHEBI:6076 DaY
ChEMBL[4]CHEMBL22587 DaY
Hemijski podaci
FormulaC35H38Cl2N8O4 
Mol. masa705,633
SMILESeMolekuli &PubHem
InChI
InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1
Key: VHVPQPYKVGDNFY-ZPGVKDDISA-N DaY
Fizički podaci
Tačka topljenja166.2 °C (331 °F)
Farmakokinetički podaci
Poluvreme eliminacije21 h
Farmakoinformacioni podaci
Trudnoća?
Pravni status
Način primeneOralno

Itrakonazol jeorgansko jedinjenje, koje sadrži 35atomaugljenika i imamolekulsku masu od 705,633Da.[5][6]

Osobine

[uredi |uredi kod]
OsobinaVrednost
Broj akceptora vodonika9
Broj donora vodonika0
Broj rotacionih veza11
Particioni koeficijent[7] (ALogP)6,4
Rastvorljivost[8] (logS, log(mol/L))-7,8
Polarna površina[9] (PSA,Å2)100,8

Reference

[uredi |uredi kod]
  1. ↑Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. ↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. ↑Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. ↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. ↑Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  6. ↑David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit
  7. ↑Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  8. ↑Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  9. ↑Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

[uredi |uredi kod]

Vanjske veze

[uredi |uredi kod]
Portal Medicina
Portal Hemija
Itrakonazol naWikimedijinoj ostavi
Izvor:https://sh.wikipedia.org/w/index.php?title=Itrakonazol&oldid=42293026
Kategorije:
[8]ページ先頭
©2009-2025 Movatter.jp